Which has higher valuation & earnings, WAY or DOCS?

Doximity has lower revenue, but higher earnings than Waystar. Doximity is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.33 $112.09M $0.70 35.44 Doximity $644.86M 7.73 $196.05M $0.85 32.89

Is WAY or DOCS more profitable?

Doximity has a net margin of 25.48% compared to Waystar's net margin of 11.18%. Doximity's return on equity of 18.06% beat Waystar's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Doximity 25.48% 18.06% 15.40%

Does the media prefer WAY or DOCS?

In the previous week, Doximity had 28 more articles in the media than Waystar. MarketBeat recorded 30 mentions for Doximity and 2 mentions for Waystar. Waystar's average media sentiment score of 1.22 beat Doximity's score of 0.12 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Doximity 1 Very Positive mention(s) 4 Positive mention(s) 23 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation and earnings, WAY or HTFL?

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.33 $112.09M $0.70 35.44 Heartflow $176.03M 24.36 -$116.79M -$1.83 N/A

Is WAY or HTFL more profitable?

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -55.82%. Waystar's return on equity of 7.03% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Heartflow -55.82% -23.52% -18.66%

Does the media favor WAY or HTFL?

In the previous week, Heartflow had 1 more articles in the media than Waystar. MarketBeat recorded 3 mentions for Heartflow and 2 mentions for Waystar. Waystar's average media sentiment score of 1.22 beat Heartflow's score of -0.03 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Heartflow 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation and earnings, WAY or SDGR?

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.33 $112.09M $0.70 35.44 Schrodinger $255.87M 8.74 -$103.26M -$0.74 N/A

Is WAY or SDGR more profitable?

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Schrodinger -20.98% -16.37% -8.19%

Does the media prefer WAY or SDGR?

In the previous week, Schrodinger had 2 more articles in the media than Waystar. MarketBeat recorded 4 mentions for Schrodinger and 2 mentions for Waystar. Waystar's average media sentiment score of 1.22 beat Schrodinger's score of 0.86 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Schrodinger 2 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, WAY or CERT?

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.33 $112.09M $0.70 35.44 Certara $418.84M 3.41 -$1.60M -$0.45 N/A

Is WAY or CERT more profitable?

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% Certara -16.75% 3.86% 2.65%

Does the media favor WAY or CERT?

In the previous week, Certara had 3 more articles in the media than Waystar. MarketBeat recorded 5 mentions for Certara and 2 mentions for Waystar. Waystar's average media sentiment score of 1.22 beat Certara's score of 0.63 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Certara 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, WAY or GDRX?

Waystar has higher revenue and earnings than GoodRx. Waystar is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Waystar $1.10B 4.33 $112.09M $0.70 35.44 GoodRx $796.85M 1.41 $30.44M $0.04 82.00

Is WAY or GDRX more profitable?

Waystar has a net margin of 11.18% compared to GoodRx's net margin of 2.07%. GoodRx's return on equity of 7.22% beat Waystar's return on equity. Company Net Margins Return on Equity Return on Assets Waystar 11.18% 7.03% 4.75% GoodRx 2.07% 7.22% 2.53%

Does the media prefer WAY or GDRX?

In the previous week, GoodRx had 1 more articles in the media than Waystar. MarketBeat recorded 3 mentions for GoodRx and 2 mentions for Waystar. Waystar's average media sentiment score of 1.22 beat GoodRx's score of 0.51 indicating that Waystar is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Waystar 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GoodRx 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Waystar (WAY) Competitors

$24.81 -0.54 (-2.13%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$24.80 0.00 (-0.02%)

As of 10/2/2026 07:36 PM Eastern

Compare

WAY vs. DOCS, HTFL, SDGR, CERT, and GDRX

Should you buy Waystar stock or one of its competitors? Waystar's main competitors and comparable companies include Doximity (DOCS), Heartflow (HTFL), Schrodinger (SDGR), Certara (CERT), and GoodRx (GDRX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare technology" industry.

How does Waystar compare to Doximity?

Waystar (NASDAQ:WAY) and Doximity (NYSE:DOCS) are both mid-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.

Doximity has lower revenue, but higher earnings than Waystar. Doximity is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.33	$112.09M	$0.70	35.44
Doximity	$644.86M	7.73	$196.05M	$0.85	32.89

Waystar has a beta of 0.18, meaning that its stock price is 82% less volatile than the broader market. Comparatively, Doximity has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market.

In the previous week, Doximity had 28 more articles in the media than Waystar. MarketBeat recorded 30 mentions for Doximity and 2 mentions for Waystar. Waystar's average media sentiment score of 1.22 beat Doximity's score of 0.12 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Doximity	1 Very Positive mention(s)	4 Positive mention(s)	23 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Doximity has a net margin of 25.48% compared to Waystar's net margin of 11.18%. Doximity's return on equity of 18.06% beat Waystar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Doximity	25.48%	18.06%	15.40%

Waystar currently has a consensus target price of $34.67, indicating a potential upside of 39.73%. Doximity has a consensus target price of $31.95, indicating a potential upside of 14.31%. Given Waystar's stronger consensus rating and higher probable upside, equities analysts clearly believe Waystar is more favorable than Doximity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92
Doximity	3 Sell rating(s)	14 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.24

87.2% of Doximity shares are owned by institutional investors. 3.5% of Waystar shares are owned by company insiders. Comparatively, 31.8% of Doximity shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Doximity beats Waystar on 10 of the 17 factors compared between the two stocks.

How does Waystar compare to Heartflow?

Waystar (NASDAQ:WAY) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk and dividends.

Waystar has a net margin of 11.18% compared to Heartflow's net margin of -55.82%. Waystar's return on equity of 7.03% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Heartflow	-55.82%	-23.52%	-18.66%

Waystar presently has a consensus price target of $34.67, suggesting a potential upside of 39.73%. Heartflow has a consensus price target of $46.25, suggesting a potential downside of 6.22%. Given Waystar's stronger consensus rating and higher probable upside, equities research analysts clearly believe Waystar is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92
Heartflow	1 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.75

Waystar has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.33	$112.09M	$0.70	35.44
Heartflow	$176.03M	24.36	-$116.79M	-$1.83	N/A

Waystar has a beta of 0.18, indicating that its stock price is 82% less volatile than the broader market. Comparatively, Heartflow has a beta of 2.73, indicating that its stock price is 173% more volatile than the broader market.

In the previous week, Heartflow had 1 more articles in the media than Waystar. MarketBeat recorded 3 mentions for Heartflow and 2 mentions for Waystar. Waystar's average media sentiment score of 1.22 beat Heartflow's score of -0.03 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Heartflow	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Waystar beats Heartflow on 12 of the 15 factors compared between the two stocks.

How does Waystar compare to Schrodinger?

Waystar (NASDAQ:WAY) and Schrodinger (NASDAQ:SDGR) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, media sentiment, risk, profitability, dividends and earnings.

Waystar has a beta of 0.18, suggesting that its share price is 82% less volatile than the broader market. Comparatively, Schrodinger has a beta of 1.62, suggesting that its share price is 62% more volatile than the broader market.

Waystar presently has a consensus price target of $34.67, indicating a potential upside of 39.73%. Schrodinger has a consensus price target of $20.80, indicating a potential downside of 31.38%. Given Waystar's stronger consensus rating and higher possible upside, research analysts plainly believe Waystar is more favorable than Schrodinger.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92
Schrodinger	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, Schrodinger had 2 more articles in the media than Waystar. MarketBeat recorded 4 mentions for Schrodinger and 2 mentions for Waystar. Waystar's average media sentiment score of 1.22 beat Schrodinger's score of 0.86 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Schrodinger	2 Very Positive mention(s)	2 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waystar has higher revenue and earnings than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.33	$112.09M	$0.70	35.44
Schrodinger	$255.87M	8.74	-$103.26M	-$0.74	N/A

79.1% of Schrodinger shares are owned by institutional investors. 3.5% of Waystar shares are owned by insiders. Comparatively, 10.1% of Schrodinger shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Waystar has a net margin of 11.18% compared to Schrodinger's net margin of -20.98%. Waystar's return on equity of 7.03% beat Schrodinger's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Schrodinger	-20.98%	-16.37%	-8.19%

Summary

Waystar beats Schrodinger on 12 of the 17 factors compared between the two stocks.

How does Waystar compare to Certara?

Waystar (NASDAQ:WAY) and Certara (NASDAQ:CERT) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, media sentiment, earnings, risk, valuation and dividends.

Waystar has a beta of 0.18, indicating that its share price is 82% less volatile than the broader market. Comparatively, Certara has a beta of 1.42, indicating that its share price is 42% more volatile than the broader market.

74.0% of Certara shares are held by institutional investors. 3.5% of Waystar shares are held by insiders. Comparatively, 1.1% of Certara shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Waystar has higher revenue and earnings than Certara. Certara is trading at a lower price-to-earnings ratio than Waystar, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.33	$112.09M	$0.70	35.44
Certara	$418.84M	3.41	-$1.60M	-$0.45	N/A

In the previous week, Certara had 3 more articles in the media than Waystar. MarketBeat recorded 5 mentions for Certara and 2 mentions for Waystar. Waystar's average media sentiment score of 1.22 beat Certara's score of 0.63 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Certara	0 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waystar presently has a consensus target price of $34.67, suggesting a potential upside of 39.73%. Certara has a consensus target price of $8.45, suggesting a potential downside of 9.72%. Given Waystar's stronger consensus rating and higher probable upside, analysts plainly believe Waystar is more favorable than Certara.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92
Certara	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.42

Waystar has a net margin of 11.18% compared to Certara's net margin of -16.75%. Waystar's return on equity of 7.03% beat Certara's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
Certara	-16.75%	3.86%	2.65%

Summary

Waystar beats Certara on 14 of the 17 factors compared between the two stocks.

How does Waystar compare to GoodRx?

Waystar (NASDAQ:WAY) and GoodRx (NASDAQ:GDRX) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

Waystar has a beta of 0.18, suggesting that its share price is 82% less volatile than the broader market. Comparatively, GoodRx has a beta of 1.69, suggesting that its share price is 69% more volatile than the broader market.

In the previous week, GoodRx had 1 more articles in the media than Waystar. MarketBeat recorded 3 mentions for GoodRx and 2 mentions for Waystar. Waystar's average media sentiment score of 1.22 beat GoodRx's score of 0.51 indicating that Waystar is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Waystar	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GoodRx	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Waystar has higher revenue and earnings than GoodRx. Waystar is trading at a lower price-to-earnings ratio than GoodRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Waystar	$1.10B	4.33	$112.09M	$0.70	35.44
GoodRx	$796.85M	1.41	$30.44M	$0.04	82.00

Waystar has a net margin of 11.18% compared to GoodRx's net margin of 2.07%. GoodRx's return on equity of 7.22% beat Waystar's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Waystar	11.18%	7.03%	4.75%
GoodRx	2.07%	7.22%	2.53%

Waystar presently has a consensus target price of $34.67, suggesting a potential upside of 39.73%. GoodRx has a consensus target price of $4.23, suggesting a potential upside of 28.88%. Given Waystar's stronger consensus rating and higher probable upside, equities analysts clearly believe Waystar is more favorable than GoodRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Waystar	0 Sell rating(s)	4 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	2.92
GoodRx	3 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.08

63.8% of GoodRx shares are held by institutional investors. 3.5% of Waystar shares are held by company insiders. Comparatively, 5.9% of GoodRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Waystar beats GoodRx on 11 of the 17 factors compared between the two stocks.

Get Waystar News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding WAY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

WAY vs. The Competition

Export

Metric	Waystar	Healthcare Technology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.76B	$1.74B	$7.15B	$13.28B
Dividend Yield	N/A	3.97%	2.54%	17.33%
P/E Ratio	35.44	20.33	274.71	26.04
Price / Sales	4.33	87.61	656.46	105.13
Price / Cash	12.73	31.81	78.87	52.62
Price / Book	1.22	6.16	10.93	6.31
Net Income	$112.09M	-$18.66M	$3.51B	$362.16M
7 Day Performance	0.45%	-2.24%	-2.00%	-1.66%
1 Month Performance	-1.04%	-1.21%	-6.19%	-4.68%
1 Year Performance	-35.79%	-21.68%	8.03%	1.57%

Waystar Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
WAY Waystar	4.3616 of 5 stars	$24.81 -2.1%	$34.67 +39.7%	-35.8%	$4.76B	$1.10B	35.44	1,700	Positive News
DOCS Doximity	4.0337 of 5 stars	$26.46 -1.4%	$32.18 +21.6%	N/A	$4.72B	$655.57M	31.13	880	Trending News Analyst Forecast
HTFL Heartflow	1.6615 of 5 stars	$50.17 -0.3%	$46.25 -7.8%	+31.0%	$4.36B	$176.03M	N/A	843	Analyst Upgrade
SDGR Schrodinger	1.3476 of 5 stars	$30.70 +1.5%	$20.50 -33.2%	+47.2%	$2.27B	$255.87M	N/A	850
CERT Certara	1.6005 of 5 stars	$8.83 +3.6%	$8.28 -6.3%	-28.4%	$1.35B	$418.84M	N/A	1,576	Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:WAY) was last updated on 10/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Waystar (WAY) Competitors